Dr. A Kavanaugh discussed Ethics #RNL2024: publication bias where positive results are likely to be published compared to those with no effects -- this is a sham study with made up data submitted to 2 different ortho journals. @rheumnow https://t.co/j6gVgA67nC

• https://twitter.com/KDAO2011/status/1751630504112095387/photo/1

Kavanaugh on Medical Ethics #RNL2024 @RheumNow Bias in research for ++ outcomes leads to fudging/biased interpretations of results Fabricated study results submitted to orthopedic journals: - 97% acceptance for positive result, 80% for no-difference result. Bias towards +outcome https://t.co/x7JJabSs4z

• https://twitter.com/ericdeinmd/status/1751630340496453851/photo/1

Kavanaugh on Medical Ethics #RNL2024 @RheumNow How do we informed consent? - How to fully inform pts in complex research? - Or paternalistic to not provide detailed info - How deep to disc risk/ben? - Easier to study in countries w/o good SoC Prior hx: prisoners, Nazi, Tuskegee

@drcassysims recommends @NIH resource: https://t.co/ebtvc2zYbE to guide lactation- updated and run by pharmacists. #RNL2024 @rheumnow

• Drugs and Lactation Database (LactMed®)

MTX and cyclophosphamide are the two drugs @DrCassySims recommends holding during breast feeding in our vasculitis patients. #RNL2024 @RheumNow

Do you get extra-cranial imaging in your GCA patients? #rheumtwitter #RNL2024 @RheumNow @anisha_dua @DrCassySims @philseo

Dr P Seo answers audience questions…he does not check ANCA levels regularly as results do not impact his actions but may induce anxiety #Vasculitis #RNL2024 @RheumNow https://t.co/GV62DF7s3y

• https://twitter.com/KDAO2011/status/1751622005172965610/photo/1

@DrCassySims checks APS ab on ALL pregnant (vasculitis) patients. "HCQ decreases neonatal lupus risk by half, meaning great reward for little risk." CS at #RNL2024 @RheumNow

Dr. P Seo's summary slide on management of #vasculitis #RNL2024 @rheumnow https://t.co/cZLI6iz1sL

• https://twitter.com/KDAO2011/status/1751620754469195915/photo/1

How Dr. P Seo manages #vasculitis patients with nonrespiratory manifestations #RNL2024 @rheumnow https://t.co/sjTXulDZ3a

• https://twitter.com/KDAO2011/status/1751620523023298852/photo/1

#RNL2024 vasculitis mavens answering questions. ⁦@RheumNow⁩ https://t.co/Lm1N666SlS

• https://twitter.com/uptoTate/status/1751620376075911627/photo/1

While #dupilumab can be used for #EGPA, be careful about using it in pts with high eosinophilia; don't taper steroids too rapidly if you use this drug. - Dr P Seo @rheumnow #RNL2024 https://t.co/YKQdtvCS0M

• https://twitter.com/KDAO2011/status/1751620282664599964/photo/1

Consider using IV Benralizumab (also an IL5 inhibitor) for #EGPA in pts where insurance won't approve SQ mepolizumab - Dr. P Seo #RNL2024 @rheumnow https://t.co/VFE76Uzb2S

• https://twitter.com/KDAO2011/status/1751619487701283179/photo/1

EGPA - Peanut butter and Jelly @philseo Respiratory symptoms and systemic disease Respiratory: non-systemic (inhalers, steroids, irrigation) IL-5 inhibs Non-respiratory: eosinophilic (myocarditis, urticaria, EE), vasculitis (MM, GN, DAH, purpura, arthralgias) #RNL2024 @RheumNow https://t.co/KTlvZ1cnfH

• https://twitter.com/ericdeinmd/status/1751619310223561188/photo/1

"EGPA is a lot like peanut butter and jelly, two separate things showing up at the same time (in terms of respiratory and systemic manifestations.)" Dr. @philseo at #RNL2024 @RheumNow https://t.co/l0WgG1caN0

• https://twitter.com/uptoTate/status/1751619043323187376/photo/1